Cost-effectiveness evaluation of pre-counseling telephone interviews before face-to-face genetic counseling in cancer genetics

Familial Cancer
Gaëlle ColletThierry Frebourg

Abstract

One of the main challenges in cancer genetics is responding to the exponential demand for genetic counseling, especially in patients with breast and/or ovarian cancer. To address this demand, we have set up a new procedure, based on pre-genetic counseling telephone interviews (PTI) followed by routing of patients: D1, a PTI is scheduled within 14 days; D7-D14, genetic counselors perform a 20 min PTI in order to establish a pre-genetic counseling file, by collecting personal and family medical history via a structured questionnaire and; D10-17, routing: pre-genetic counseling appointment files are analyzed by a cancer geneticist with 3 possible conclusions: (a) priority face-to-face genetic counseling (FTFGC) appointment with a cancer geneticist, if the genetic test results have an immediate therapeutic impact; (b) non-priority FTFGC with a genetic counselor, or (c) no FTFGC required or substitution by a more appropriate index case. In the context of breast and/or ovarian cancer, 1012 patients received PTIs, 39.1% of which did not lead to FTFGC. The mean delay for non-priority FTFGC was maintained at 18 weeks and priority FTFGC appointments were guaranteed within 8 weeks. The required resources for 1012 patients was estimated at...Continue Reading

References

Sep 24, 2004·British Journal of Cancer·A C AntoniouD F Easton
Jan 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc D SchwartzLesley King
Feb 26, 2014·Breast Cancer Research and Treatment·Antonis ValachisPehr Lind
Sep 10, 2015·European Journal of Human Genetics : EJHG·Hildegunn Høberg-VettiNicoline Hoogerbrugge
Apr 28, 2016·Breast Cancer Research and Treatment·Dana Madorsky-FeldmanEitan Friedman
Jun 9, 2016·Journal of Genetic Counseling·Andrea L ShugarSohnee Ahmed
Jun 22, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anita Y KinneyMarc D Schwartz
May 12, 2017·Therapeutic Advances in Medical Oncology·Tarra Evans, Ursula Matulonis

❮ Previous
Next ❯

Citations

Mar 14, 2020·Therapeutic Advances in Medical Oncology·Zoé NeviereFlorence Joly

❮ Previous
Next ❯

Software Mentioned

BOADICEA

Related Concepts

Related Feeds

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Related Papers

Soins; la revue de référence infirmière
C Harel
Journal of Thoracic Disease
Ashley H WoodsonJennifer K Litton
Otolaryngologic Clinics of North America
K S ArnosM P Wilson
© 2022 Meta ULC. All rights reserved